325 related articles for article (PubMed ID: 12764552)
21. Preclinical Evaluation of a Potential GSH Ester Based PET/SPECT Imaging Probe DT(GSHMe)₂ to Detect Gamma Glutamyl Transferase Over Expressing Tumors.
Khurana H; Meena VK; Prakash S; Chuttani K; Chadha N; Jaswal A; Dhawan DK; Mishra AK; Hazari PP
PLoS One; 2015; 10(7):e0134281. PubMed ID: 26221728
[TBL] [Abstract][Full Text] [Related]
22. Techniques for imaging neuroscience.
Turner R; Jones T
Br Med Bull; 2003; 65():3-20. PubMed ID: 12697613
[TBL] [Abstract][Full Text] [Related]
23. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.
Tatsch K
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):711-4. PubMed ID: 11976813
[No Abstract] [Full Text] [Related]
24. Molecular imaging of regional brain tumor biology.
Spence AM; Muzi M; Krohn KA
J Cell Biochem Suppl; 2002; 39():25-35. PubMed ID: 12552599
[TBL] [Abstract][Full Text] [Related]
25. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of prognostic integrin α2β1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection.
Chung YH; Hsu PH; Huang CW; Hsieh WC; Huang FT; Chang WC; Chiu H; Hsu ST; Yen TC
Mol Pharm; 2014 Nov; 11(11):3904-14. PubMed ID: 25153169
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.
Valk PE; Jagust WJ; Derenzo SE; Huesman RH; Geyer AB; Budinger TF
Radiology; 1990 Sep; 176(3):783-90. PubMed ID: 2389037
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and preliminary biological evaluation of S-11C-methyl-D-cysteine as a new amino acid PET tracer for cancer imaging.
Huang T; Tang G; Wang H; Nie D; Tang X; Liang X; Hu K; Yi C; Yao B; Tang C
Amino Acids; 2015 Apr; 47(4):719-27. PubMed ID: 25534431
[TBL] [Abstract][Full Text] [Related]
29. Micro-PET imaging and small animal models of disease.
Herschman HR
Curr Opin Immunol; 2003 Aug; 15(4):378-84. PubMed ID: 12900267
[TBL] [Abstract][Full Text] [Related]
30. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
[TBL] [Abstract][Full Text] [Related]
31. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
32. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
[TBL] [Abstract][Full Text] [Related]
33. [Positron emission tomography. A new measurement method for imaging of regional and biochemical parameters].
Bolwig TG; Haunsø S; Hove JD; Hesse B; Højgaard L; Jensen M; Paulson OB; Svendsen JH; Sørensen SS
Ugeskr Laeger; 1994 Oct; 156(43):6341-7. PubMed ID: 7810006
[TBL] [Abstract][Full Text] [Related]
34. PET studies in psychiatry: validity, accuracy and future.
Vallabhajosula S; Buchsbaum M
J Nucl Med; 1994 Jan; 35(1):24-6. PubMed ID: 8271055
[No Abstract] [Full Text] [Related]
35. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
36. [Positron emission tomography with L-[S-methyl-11C]-methioine and its biodistribution].
Chen LG; Zhou MJ; Tan AW; Wang SX; He SZ; Ding ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):834-5. PubMed ID: 17584651
[TBL] [Abstract][Full Text] [Related]
37. 18F-CPFPX PET identifies changes in cerebral A1 adenosine receptor density caused by glioma invasion.
Bauer A; Langen KJ; Bidmon H; Holschbach MH; Weber S; Olsson RA; Coenen HH; Zilles K
J Nucl Med; 2005 Mar; 46(3):450-4. PubMed ID: 15750158
[TBL] [Abstract][Full Text] [Related]
38. Switching on the lights for gene therapy.
Winkeler A; Sena-Esteves M; Paulis LE; Li H; Waerzeggers Y; Rückriem B; Himmelreich U; Klein M; Monfared P; Rueger MA; Heneka M; Vollmar S; Hoehn M; Fraefel C; Graf R; Wienhard K; Heiss WD; Jacobs AH
PLoS One; 2007 Jun; 2(6):e528. PubMed ID: 17565381
[TBL] [Abstract][Full Text] [Related]
39. Molecular neuroimaging: from conventional to emerging techniques.
Hammoud DA; Hoffman JM; Pomper MG
Radiology; 2007 Oct; 245(1):21-42. PubMed ID: 17885179
[TBL] [Abstract][Full Text] [Related]
40. New developments of dopaminergic imaging in Parkinson's disease.
Varrone A; Halldin C
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):68-82. PubMed ID: 22460161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
